Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.8 USD | +2.20% | -3.58% | +29.90% |
05-24 | Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing | MT |
05-21 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |
Sales 2024 * | 754M 1.03B | Sales 2025 * | 826M 1.13B | Capitalization | 2.75B 3.75B |
---|---|---|---|---|---|
Net income 2024 * | -395M -540M | Net income 2025 * | -194M -265M | EV / Sales 2024 * | 2.98 x |
Net cash position 2024 * | 503M 688M | Net cash position 2025 * | 424M 579M | EV / Sales 2025 * | 2.81 x |
P/E ratio 2024 * |
-6.97
x | P/E ratio 2025 * |
-13.2
x | Employees | 1,022 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.58% |
Latest transcript on PTC Therapeutics, Inc.
1 day | +2.20% | ||
1 week | -3.58% | ||
Current month | +11.35% | ||
1 month | +11.35% | ||
3 months | +12.05% | ||
6 months | +55.52% | ||
Current year | +29.90% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Klein
CEO | Chief Executive Officer | 52 | 19-09-30 |
Pierre Gravier
DFI | Director of Finance/CFO | 39 | 23-07-12 |
Ellen Welch
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Glenn Steele
BRD | Director/Board Member | 79 | 15-06-14 |
Chairman | 72 | 01-07-31 | |
David Southwell
BRD | Director/Board Member | 63 | 05-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.35% | 14 M€ | -6.04% | ||
0.36% | 0 M€ | 0.00% | - | |
0.25% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-30 | 35.81 | +2.23% | 983,239 |
24-05-29 | 35.03 | -3.95% | 786,455 |
24-05-28 | 36.47 | -1.96% | 844,772 |
24-05-24 | 37.2 | +0.19% | 540,532 |
24-05-23 | 37.13 | -3.91% | 848,100 |
Delayed Quote Nasdaq, May 30, 2024 at 03:59 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.90% | 2.75B | |
+8.92% | 114B | |
+10.48% | 105B | |
-1.83% | 21.73B | |
-6.45% | 23.83B | |
-10.39% | 18.1B | |
-42.36% | 16.34B | |
-14.45% | 16.13B | |
+3.76% | 13.75B | |
+28.94% | 11.76B |
- Stock Market
- Equities
- PTCT Stock